HER2 gene mutations and matrix biomarkers in breast canceron September 5, 2025 at 10:49 am
Publication date: December 2025 Source: Clinical Biochemistry, Volume 140 Author(s): Leyla Karimova, Gulnara Azizova, Ilaha Shahverdiyeva
ccinfoadmin
Elevated level of platelet factor 4 in follicular fluid is associated with polycystic ovary syndromeon September 5, 2025 at 10:49 am
Publication date: December 2025 Source: Clinical Biochemistry, Volume 140 Author(s): Wenqi Wang, Guangxi Wang, Xiaoming Niu, Zhonglan Li, Mingfu Zhang, Zhenchao Xu, Tou Liu
Circulating free PSA in breast cancer patients: is it a reliable biomarker?on September 4, 2025 at 3:43 pm
Publication date: December 2025 Source: Clinical Biochemistry, Volume 140 Author(s): Vanessa Susini, Maria Franzini, Silvia Ursino, Maria Ghilardi, Riccardo Morganti, Cristian Scatena, Irene Bianco, Alessandro Mazzoni, Matteo Ghilli
Serum GPR37 as a novel biomarker for disease activity, disability, and differential diagnosis in NMOSDon September 4, 2025 at 2:43 pm
Publication date: 1 January 2026 Source: Clinica Chimica Acta, Volume 578 Author(s): Xiaotong Li, Wencan Jiang, Ting Xu, Yaowei Ding, Junhui Xiong, Haoran Li, Mengwen Zou, Zhen Wang, Haihong Wang, Guojun Zhang
Assay-specific machine-learning models converting insulin to C-peptide or C-peptide index and C-peptide to HOMA2-IR: Single-center retrospective observational studyon September 4, 2025 at 2:43 pm
Publication date: 1 January 2026 Source: Clinica Chimica Acta, Volume 578 Author(s): Yuichiro Iwamoto, Tomohiko Kimura, Toshitomo Sugisaki, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Corrigendum to “Validation of an assay for NGAL in a Pediatric Population” [Practical Laboratory Medicine, PLABM 486, e00486]on September 4, 2025 at 2:43 pm
Publication date: September 2025 Source: Practical Laboratory Medicine, Volume 46 Author(s): Nazmin Bithi, Ridwan B. Ibrahim, Estella Tam, Radwa Almamoun, Annett C. Frenk Oquendo, Ayse Akcan-Arikan, Sridevi Devaraj
The Devil Is in the Details: Clinical Relevance of Serologic Antibody Titers to Predict the Diagnosis of Celiac Disease in Pediatric Type 1 Diabetes
Clin Chem. 2025 Sep 3:hvaf102. doi: 10.1093/clinchem/hvaf102. Online ahead of print. NO ABSTRACT PMID:40899701 | DOI:10.1093/clinchem/hvaf102
Modern Low-Density Lipoprotein Cholesterol Formulas Outperform Direct Methods in Patients with Hypertriglyceridemia and Low Levels of Low-Density Lipoprotein Cholesterol
Clin Chem. 2025 Sep 3:hvaf099. doi: 10.1093/clinchem/hvaf099. Online ahead of print. ABSTRACT BACKGROUND: Direct measurement of low-density lipoprotein cholesterol (LDL-C) is widely used and recommended by professional society guidelines despite its potential limitations in patients with hypertriglyceridemia and low LDL-C. This study evaluated the performance of 3 direct LDL-C (LDL-CD) assays, 2 modern LDL-C calculation … Read more
Analytical validation of laboratory-collected fecal immunochemical test for multi-target stool RNA teston September 3, 2025 at 12:43 pm
Publication date: Available online 3 September 2025 Source: Practical Laboratory Medicine Author(s): Erica K. Barnell, Kimberly Kruse, Elizabeth M. Wurtzler, Maya Crowder Scott, Andrew R. Barnell, Eric J. Duncavage
Addition of Lyso-Gb1 to enzyme activity to first-tier test for Gaucher in DBS improves diagnostic accuracy and reduces patient recall rateon September 3, 2025 at 12:43 pm
Publication date: 1 January 2026 Source: Clinica Chimica Acta, Volume 578 Author(s): Dana Velásquez Rivas, Lucas Silvestroff, Sofía Baffa Trasci, Joaquín Frabasil